$7.55
arrow_drop_up0.53%Key Stats | |
---|---|
Open | $7.95 |
Prev. Close | $8.00 |
EPS | -0.67 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 7.39 | 8.66 |
52 Week Range | 5.05 | 14.99 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.67 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why
Wall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should Know
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28%
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression